Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1016/j.celrep.2021.108737

http://scihub22266oqcxt.onion/10.1016/j.celrep.2021.108737
suck pdf from google scholar
33545052!7835103!33545052
unlimited free pdf from europmc33545052    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid33545052      Cell+Rep 2021 ; 34 (7): 108737
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2 #MMPMID33545052
  • Bates TA; Weinstein JB; Farley S; Leier HC; Messer WB; Tafesse FG
  • Cell Rep 2021[Feb]; 34 (7): 108737 PMID33545052show ga
  • In the ongoing coronavirus disease 2019 (COVID-19) pandemic, there remain unanswered questions regarding the nature and significance of the humoral immune response toward other coronavirus infections. Here, we investigate the cross-reactivity of antibodies raised against the first severe acute respiratory syndrome coronavirus (SARS-CoV) for their reactivity toward SARS-CoV-2. We extensively characterize a selection of 10 antibodies covering all of the SARS-CoV structural proteins: spike, membrane, nucleocapsid, and envelope. Although nearly all of the examined SARS-CoV antibodies display some level of reactivity to SARS-CoV-2, we find only partial cross-neutralization for the spike antibodies. The implications of our work are two-fold. First, we establish a set of antibodies with known reactivity to both SARS-CoV and SARS-CoV-2, which will allow further study of both viruses. Second, we provide empirical evidence of the high propensity for antibody cross-reactivity between distinct strains of human coronaviruses, which is critical information for designing diagnostic and vaccine strategies for COVID-19.
  • |Antibodies, Viral/*immunology[MESH]
  • |COVID-19/immunology/virology[MESH]
  • |Coronavirus Infections/immunology/virology[MESH]
  • |Cross Reactions/immunology[MESH]
  • |HEK293 Cells[MESH]
  • |Humans[MESH]
  • |Immunity, Humoral/immunology[MESH]
  • |Pandemics[MESH]
  • |SARS-CoV-2/genetics/*immunology[MESH]
  • |Severe acute respiratory syndrome-related coronavirus/genetics/*immunology[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box